<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2013-05-22 12:29:43Organic chemistry Chemistry Ustekinumab Janssen Pharmaceutica Darunavir Paliperidone Golimumab Acuvue Nicorette Centocor Johnson & Johnson Medicine |
Add to Reading List |
Johnson Medal Awardees 1 YEAR 2012 | July 8, 2010 Invega Sustenna Billing Webinar Attendees • CBHC – Brian Turner • ACS – John Padilla, Claims Operations SupervisorDocID: 1nr9S - View Document |
| Xeplion, INN-paliperidone palmitateDocID: 1e0I3 - View Document |
| 5.2 ARIPIPRAZOLE, 300 mg injection: modified release [1 x 300 mg vial] (&) inert substance diluent [2 x 3 mL syringe], 400 mg injection: modified release [1 x 400 mg vial] (&) inert substance diluent [2 x 3 mL syringeDocID: 17I3Q - View Document |
| DOC DocumentDocID: 17hD7 - View Document |
| PDF DocumentDocID: 179Jv - View Document |